| 英文别名 |
Ioversol;n,n'-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide;1-N,3-N-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide;MP-328;[N,N'-bis-(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)(2-hydroxyethyl)amino]-2,4,6-triiodoisophthalamide];Ioversolum [Latin];N,N'-bis(2,3-dihydroxypropyl)-5[(hydroxyacetyl)-(2-hydroxyethyl)-amino]-2,4,6-triiodo-1,3-benzenedicarboxamide;N,N'-bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide;Optiray;Optiray 160;Optiray 240;Optiray 320;Optiray 350;UNII-N3RIB7X24K;N,N′-Bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)(2-hydroxyethyl)amino]-2,4,6-triiodo-1,3-benzenedicarboxamide;N,N′-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)glycolamido]-2,4,6-triiodoisophthalamide;1,3-Benzenedicarboxamide, N,N′-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)(2-hydroxyethyl)amino]-2,4,6-triiodo- (9CI);N1,N3-Bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)(2-hydroxyethyl)amino]-2,4,6-triiodo-1,3-benzenedicarboxamide (ACI);MP 328;P 530;P 530 (contrast agent);G12764;Ioversol (USAN:USP:INN:BAN);N,N'-Bis (2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl) -glycolamido] -2,4,6-triiodoisophthalamide;s5013;Prestwick0_000878;AKOS015896385;DB09134;NS00008942;IOVERSOL [INN];IOVERSOL (MART.);ioversolo;IOVERSOL (USP MONOGRAPH);Q-201247;CCG-213209;AMDBBAQNWSUWGN-UHFFFAOYSA-N;LOVERSOL;N1,N3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-(2-hydroxyethyl)acetamido)-2,4,6-triiodoisophthalamide;IOVERSOL [USP MONOGRAPH];Optiray300;HMS3714P17;AB00513943;BSPBio_000955;NCGC00179364-01;CS-7483;HMS2097P17;Optiray350;Ioversol (JAN/USP/INN);1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)(2-hydroxyethyl)amino)-2,4,6-triiodo-;EN300-19767831;AS-12851;IOVERSOL [JAN];N1,N3-bis(2,3-dihydroxypropyl)-5-[2-hydroxy-N-(2-hydroxyethyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide;D01555;NCGC00016956-01;N,N'-Bis(2,3-dihydroxypropyl)-5-(N-(2-hydroxyethyl)glycolamido)-2,4,6-triiodoisophthalamide;Pharmakon1600-01503837;IOVERSOL [ORANGE BOOK];Optiray 300;NSC760064;SPBio_002876;DTXSID2045521;BRD-A65818372-001-05-3;Tox21_110709;Ioversolum (Latin);SR-01000872680-1;SR-01000872680;N3RIB7X24K;HY-B1410;Q6064187;CAS-87771-40-2;NCGC00179364-03;IOVERSOL [USAN];Ioversolum;CHEMBL1200614;IOVERSOL [WHO-DD];AB00513943_02;8771-40-2;HMS1570P17;Tox21_110709_1;IOVERSOL [MART.];87771-40-2;BRD-A65818372-001-01-2;NSC-760064;IOVERSOL [USP-RS];IOVERSOL [VANDF];Prestwick2_000878;SCHEMBL24711;Optiray320;BRN 7155654;Ioversol [USAN:USP:INN:BAN];N,N'-Bis (2,3-dihydroxypropyl)-5-(N-(2-hydroxyethyl) -glycolamido) -2,4,6-triiodoisophthalamide;Optiray (TN);Prestwick1_000878;DTXCID0025521;BCP11109;IOVERSOL (USP-RS);IOVERSOL [MI];CHEBI:31717;V08AB07;BPBio1_001051;Prestwick3_000878;AC-536;ioversol;N,N'-Bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl... |